2[10]Cazzola M,Marco FD,Santus P, et al. Pharmacodynamic effects of single inhalated doses of a formoterol tiotropium and their combination in patients with COPD [ J ] . Pulm Pharmacol Ther,2004,17(1) :35.
3[11]DUrzo AD, DE Salvo MC, Ramirez - Rivera A , et al. In patients with COPD treatment with a combination of formotrol and ipratropium:a 3 week randomized double - blind,withinpatients, multicenter study[J]. Chest ,2001,119(5): 1 347.
4[7]Mahler DA, Wire P, Horstman D, et al. Effectiveness of fluticasone propionate and salmeterol combination delivered via the discuss device in the treatment of chronic pulmonary disease [J]. Am J Respir Crit Care Med ,2002,166(8): 1 084.
5[8]Hanania NA, Darken P, Horstman D, et al. The efficacy and safety of fluticasone propionate ( 250mocrog )/salmeterol (50microg) combined in the diskus inhaler for the treatment of COPD[J]. Chest ,2003,124(3): 1 661.
6[9]Friend M, Serby CW, Menjoge SS. Pharmaco - econonomic evaluation of a combination of ipratropium plus albuterol cpmpared with ipratropium alone and albuterol alone in COPD [J]. Chest, 1999,115(3) :635.
7[1]Politiek MJ, Boorsman M, Aalbers R. Comparison of formoterol and salbutamol and salmeterol in methacholine - induced severe bronchoconstriction [J] . Eur Respir J, 1999,13 (5): 988.
8[3]Wong GW, Ko FW, Lau TS, et al. Temporal relationship between air pollution and hospital admission for asthmatic childen in Hong Kong[J]. Exp Allergy ,2001,31:565.
9[5]Shrewsbury S, Pyke S, Britton M. Meta- analysis of increasesd dose of inhaled steroid or addition of salmeterol in symptomatic asthma(MIASMA) [J]. BMJ ,2000,320(7 246): 1 368.
10[6]Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial [J]. Lancet,2003,361 (9 395 ) :449.
